Bamlanivimab + Etesevimab Reduces SARS-CoV-2 Viral Load
No significant reduction seen in viral load at day 11 with bamlanivimab monotherapy in mild-to-moderate COVID-19
Opioid Use May Contribute to Risk for Pancreatic Cancer
At the state level, opioid death rate at four years prior predicted the initial incidence of pancreatic cancer
Physician’s Briefing Weekly Coronavirus Roundup
FDA Approves First Monthly Injectable Regimen for HIV
Trials show virologic suppression in comparable numbers of patients receiving monthly injection with Cabenuva, daily current antiretroviral regimen
Antibody Drug May Protect Nursing Home Residents, Staff From COVID-19
Preliminary results of the study conducted by drug maker Eli Lilly have not been peer-reviewed or published
Tocilizumab Does Not Improve Outcomes in Severe COVID-19
Tocilizumab plus standard care no better for improving clinical outcomes at 15 days and may increase mortality
Impact of Antidepressants Examined in Back Pain, Osteoarthritis
SNRIs have small, not clinically important effect on back pain; may have clinically important effect on osteoarthritis pain
President Biden Unveils Details of National Pandemic Response Plan
On Wednesday, Biden signed three executive orders relating to the coronavirus pandemic shortly after taking office
Denosumab Studied for Prosthesis-Related Osteolysis
Fewer osteoclasts seen at osteolysis membrane-bone interface with denosumab versus placebo in patients undergoing revision hip arthroplasty
Aspirin Use Cuts CRC Risk in Those Initiating Use Before Age 70
Inverse association seen for aspirin users starting use before age 70, but not for those initiating use at or after age 70 years
